December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtaiBeckley Inc. - Common Stock (NQ:ATAI)

4.200 +0.060 (+1.45%)
Official Closing Price Updated: 4:15 PM EDT, May 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AtaiBeckley Inc. - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
30 31 Next >
Psychedelic Stock Gainers And Losers From December 21, 2022 ↗
 
Via Benzinga
News headline image
3 (Risky) Tricks for Finding Monster Growth Stocks ↗
Stocks with big upside potential often have significant risks, too. 
Via The Motley Fool
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
ATAI Life Sciences's Return On Capital Employed Insights ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 19, 2022 ↗
 
Via Benzinga
News headline image
atai Life Sciences Initiates Phase 2b proof-of-concept trial of RL-007 for Cognitive Impairment Associated with Schizophrenia
From atai Life Sciences
Via GlobeNewswire
Psychedelic Stock Gainers And Losers From December 14, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 13, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 9, 2022 ↗
 
Via Benzinga
News headline image
Major Psychedelic Drug Stocks Down Another 7% This Week; Now Down 54% YTD ↗
The 6 largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of 10 different psychedelic substances are down again this week. 
Via Talk Markets
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 7, 2022 ↗
 
Via Benzinga
News headline image
The atai Fellowship Fund in Psychedelic Neuroscience Announces its First Cohort at Massachusetts General Hospital
From atai Life Sciences
Via GlobeNewswire
News headline image
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans ↗
Part one of a three-part series. The first medical-grade drug candidate of the psychedelic ayahuasca is being developed. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From December 12, 2022 ↗
 
Via Benzinga
News headline image
Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD ↗
Today's article highlights the performance of the largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of ten (10) different psychedelic substances. 
Via Talk Markets
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Major Psychedelic Drug Stocks Went Up 7% This Week; Still Down 46% YTD ↗
The 6 major psychedelic stocks researching the treatment of a variety of mental illnesses were UP 7% this week and are UP 3 % in the last 6 weeks. The 6 therapy clinic stocks went UP 3% this week and... 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From December 2, 2022 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From December 1, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 30, 2022 ↗
 
Via Benzinga
Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
3 Big Trends Shaking Up Psychedelic Stocks ↗
Major positive shifts are happening, but the field faces new headwinds too. 
Via The Motley Fool
News headline image
atai Life Sciences Strengthens Leadership Team with Appointment of Dr. Sahil V. Kirpekar as Chief Business Officer
From atai Life Sciences
Via GlobeNewswire
News headline image
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 25, 2022 ↗
 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.